glp 1 cardiovascular risk GLP-1 Agonists in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 and the cardiovascular system
Description
A., & Koutoukidis, D
By India Hanley June 17, 2024 Celebrities aren't the only ones achieving success with GLP-1 weight loss medications
E., & Thun, M
However, like any medication, Ozempic carries potential side effects, ranging from mild gastrointestinal discomfort to more serious concerns like pancreatitis and gallbladder issues
As a pharmacist passionate about patient outcomes and intrigued by pharmaceutical innovation, I'm eager yet vigilantready to embrace orforglipron if ongoing studies confirm its long-term safety and efficacy
doi: 10.1016/j.jpeds.2014.09.019 30 De LenDDLiCDelsonMIMatschiskyFMStanleyCAStoffersDA
